Avivi I, Cohen YC, Joffe E, Benyamini N, Held-Kuznetsov V, Trestman S, et al. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome. Hematol Oncol 2016.
Moreau C, Autier B, Cavey T, Rouger E, Norwood J, Bendavid C, et al. Evaluation of the Impact of Renal Failure on Correlation and Concordance between 2 Free Light Chain Assays. Clin Lymphoma Myeloma Leuk 2016.
de Mel S, Chen Y, Gopalakrishnan SK, Ooi M, Teo C, Tan D, et al. The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma. Singapore Med J 2016.
P118: Heavy/Light Chain Immunoassays for Monitoring of a Multiple Myeloma Patient.
J. Radek1, P. Birkner1, I. Gruber1, D. Trubert-Exinger1
P1206: Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Author(s): M.M. Voortman, T. Stojakovic, M. Jehna, H. Scharnagl, S. Ropele, T. Seifert-Held, J.-J. Archelos, S. Fuchs, C. Enzinger, F. Fazekas, M. Khalil
